Molekulaardiagnostika kordamisküsimused
infectious agents, and with time those genomes will be known, if they are not already.
Thus, the technological ability to detect any infectious agent rapidly and specifically are
currently available. The only remaining blockades to the use of PCR as a standard tool of
diagnosis are in its cost and application, neither of which is insurmountable. The
diagnosis of a few diseases will not benefit from the development of PCR methods, such
as some of the clostridial diseases (tetanus and botulism). These diseases are
fundamentally biological poisonings by relatively small numbers of infectious bacteria
that produce extremely potent neurotoxins. A significant proliferation of the infectious
agent does not occur, this limits the ability of PCR to detect the presence of any bacteria.
5.Millest tulevad vead immunoloogiliste meetodite kasutamisel nakkushaiguste
diagnoosimisel? Milliseid vigu ja kuidas saab vältida?
6.Mis on meetodi tundlikkus?
annaabi.ee 
